Articles On Optiscan Imaging (ASX:OIL)
| Title | Source | Codes | Date |
|---|---|---|---|
|
Closing Bell: Today’s biggest small cap movers on the ASX
A quick wrap of the ASX’s key winners and losers on Monday, September 7. Data is taken after the market closes at 4pm AEST. Stocks highlighted in yellow made market-moving announcements during the day. Today 847 stocks rose, 575 declined an... |
Stockhead | OIL | 4 years ago |
|
Optiscan Imaging Ltd - Government grant to support Melbourne Dental School Oral Cancer Trial
Our summary of Optiscan Imaging Ltd's recent announcement What's happened? Optiscan Imaging Limited (ASX:OIL) has been awarded a grant of almost $1 million by the Australian Government, which will help fund a trial to improve screening, dia... |
SmallCapInsider | OIL | 4 years ago |
|
Closing Bell: Today’s biggest small cap movers on the ASX
A quick wrap of the key winners and losers on Friday, June 26. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made market-moving announcements during the day. Today 907 stocks rose, 484 declined and 722 were... |
Stockhead | OIL | 4 years ago |
|
Check up: COVID-19 still sells but investors are looking for the next endorphin hit
Here’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small cap health stocks, 61 were in positive territory over the last fortnight, 10 were flat and 66 saw their share prices fall. Code Name... |
Stockhead | OIL | 4 years ago |
|
Optiscan Imaging updates on the development of a new clinical system for oral cancer screening and surgery, ongoing clinical trials and new China distributor
|
Proactive Investors | OIL | 5 years ago |
|
Optiscan Imaging makes China appointment as part of multi-distributor model for cancer screening
|
Proactive Investors | OIL | 5 years ago |
|
Health: Immutep bounces off decade-long lows thanks to cash from GSK
Cancer-fighting biotech Immutep (ASX:IMM) has risen off 10-year-long lows after flagging a payment of $7.4m from British pharma giant GSK. Immutep shares got a 14 per cent boost to 2.5c, after closing at 2.2c on Friday. The share price has... |
Stockhead | OIL | 5 years ago |
|
Optiscan secures major milestone after approval for prestigious cancer trial
Medical equipment maker Optiscan Imaging (ASX: OIL) has achieved a significant milestone as part of its overarching development strategy after its cutting-edge “virtual biopsy technology” was selected for use in an oral cancer clinical tria... |
SmallCaps | OIL | 5 years ago |